Search

Displaying results 8331 - 8340 of 8693 in total
  1. Drug

    Gemcabene

    go.drugbank.com/drugs/DB05123
    Investigational

    Gemcabene is a new drug that lowers low-density lipoprotein cholesterol (LDL-C), decreases triglycerides, and raises high-density lipoprotein cholesterol (HDL-C).

  2. Drug

    PRX-03140

    go.drugbank.com/drugs/DB05596
    Investigational

  3. Drug

    OP-145

    go.drugbank.com/drugs/DB05672
    Experimental

    OP-145 is a synthetic antimicrobial peptide developed from human cathelicidin LL-37.

  4. Drug

    Elsiglutide

    go.drugbank.com/drugs/DB06336
    Investigational

  5. Drug

    SPC2968

    go.drugbank.com/drugs/DB06351
    Investigational

    SPC2968 is a synthetic antisense oligodeoxynucleotide targeting hypoxia-inducible factor-1alpha (HIF-1alpha). It was under investigation in clinical trial NCT02564614 (A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic ...

  6. Drug

    Tarazepide

    go.drugbank.com/drugs/DB06435
    Experimental

  7. Drug

    Labradimil

    go.drugbank.com/drugs/DB06549
    Investigational

  8. Drug

    Lixivaptan

    go.drugbank.com/drugs/DB06666
    Investigational

  9. Drug

    Custirsen

    go.drugbank.com/drugs/DB05487
    Investigational

    Custirsen acts as a selective estrogen receptor modulator (SERM), inhibiting the proliferation of estrogen-sensitive breast cancer cells. … This agent also inhibits growth and induces apoptosis of glioblastoma cells via a mechanism independent of estrogen receptor-related mechanisms.

  10. Drug

    TRU-015

    go.drugbank.com/drugs/DB05580
    Investigational